Highlights from recent Life Science venture capital news.

28.02.2012 – San Jose, CA

GeneWeave Biosciences Secures $12M in Funding

GeneWeave Biosciences has raised $12 million in a series A round of venture capital led by Decheng Capital. Existing investors Claremont Creek Ventures and X/Seed Capital also participated in the round. As a result, Min Cui, managing director at Decheng Capital, will join the company’s board. http://www.pehub.com/138036/geneweave-biosciences-inks-12m/

28.02.2012 – New York, NY

Hello Health Secures $10M in Funding

Hello Health® announced today that it has raised $10M in a combination of common and preferred shares, and issuance of convertible debentures through its parent company, Myca® Health.  This equity capital was privately funded by a select group of investors. http://news.techfinance.ca/hello-health-secures-10-million-in-funding/

This Week In Venture Capital is brought to you by VM Index from Venture Market Intelligence – Venture Capital made easier

VM Index is an online Life Science, Med Tech & Biotech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.